# FDA 483 - Novo Nordisk Pharmaceutical Industries LP - July 13, 2023

Source: https://www.globalkeysolutions.net/records/483/novo-nordisk-pharmaceutical-industries-lp/07f68227-1226-420a-b605-fb4e3475849f

> FDA 483 for Novo Nordisk Pharmaceutical Industries LP on July 13, 2023. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Novo Nordisk Pharmaceutical Industries LP
- Inspection Date: 2023-07-13
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [EIR - 2022-05-13](https://www.globalkeysolutions.net/records/eir/novo-nordisk-pharmaceutical-industries-lp/37bcd4d9-2dd4-4e51-9349-32184213bfa8)
- [EIR - 2023-07-13](https://www.globalkeysolutions.net/records/eir/novo-nordisk-pharmaceutical-industries-lp/272bae5d-2bf6-49db-a557-0b48425a5816)

## Related Officers

- [Seneca D. Toms](https://www.globalkeysolutions.net/people/seneca-d-toms/3eda62a2-4c12-438f-805a-5e3efb0f2f94)
- [Medical Officer at FDA](https://www.globalkeysolutions.net/people/brittny-c-cargo/a3479241-5390-4ddb-b892-df0bac1c89cf)

Company: https://www.globalkeysolutions.net/companies/novo-nordisk-pharmaceutical-industries-lp/ae9a8861-e1ab-4878-a69f-e2f23284d455

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c